Peter Arlett

European Medicines Agency — Netherlands

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

27h-index3.1kcitations89works7.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pharmacovigilance and Adverse Drug Reactions(42), Health Systems, Economic Evaluations, Quality of Life(24), Pharmaceutical Economics and Policy(19), Biosimilars and Bioanalytical Methods(16), Pharmaceutical industry and healthcare(12)

Publications89 total

Advancing pharmacogenomics in medicines regulation and clinical practice: a call for collaborative action
Nature Reviews Drug Discovery·2025
A Fast Path from Innovation to Safe and Effective Medicines
Clinical Pharmacology & Therapeutics·2025Open Access
Optimizing Patient Registries for Regulatory Decision Making ‐ Key Learnings From an <scp>HMA</scp>/<scp>EMA</scp> Multistakeholder Workshop
Clinical Pharmacology & Therapeutics·2025· 10 citedOpen Access
Clinical Evidence 2030
Clinical Pharmacology & Therapeutics·2025· 18 citedOpen Access
Artificial Intelligence in European Medicines Regulation: From Vision to Action. Harnessing the Capabilities of Artificial Intelligence for the Benefit of Public and Animal Health
Clinical Pharmacology & Therapeutics·2024· 2 citedOpen Access
Collaborative Real‐World Evidence Among Regulators: Lessons and Perspectives
Clinical Pharmacology & Therapeutics·2024· 4 citedOpen Access
Sharing Is Caring? International Society for Pharmacoepidemiology Review and Recommendations for Sharing Programming Code
Pharmacoepidemiology and Drug Safety·2024· 9 citedOpen Access
The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System
Drug Safety·2024· 6 citedOpen Access
Real‐World Evidence to Support EU Regulatory Decision Making—Results From a Pilot of Regulatory Use Cases
Clinical Pharmacology & Therapeutics·2024· 25 citedOpen Access
Accelerating clinical trials in the EU (ACT EU): transforming the EU clinical trials landscape
Nature Reviews Drug Discovery·2024· 7 cited
Sharing is caring? International Society of Pharmacoepidemiology review and recommendations for sharing of programming code
2024Open Access
European Medicines Agency seeks stakeholders' views on future transparency measures for clinical trials
British Journal of Clinical Pharmacology·2023· 1 citedOpen Access
RCTs and real world evidence are complementary, not alternatives
BMJ·2023· 21 cited
Artificial intelligence in European medicines regulation
Nature Reviews Drug Discovery·2022· 21 cited
A natural language processing approach towards harmonisation of European medicinal product information
PLoS ONE·2022· 5 citedOpen Access
HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force
Pharmacoepidemiology and Drug Safety·2022· 91 citedOpen Access
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force
Value in Health·2022· 48 citedOpen Access
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
Nature Communications·2022· 95 citedOpen Access
The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions
Drug Safety·2021· 13 citedOpen Access
Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
Clinical Pharmacology & Therapeutics·2021· 162 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Xavier Kurz(15), Jim Slattery(8), Kevin Blake(8), Sabine M. J. M. Straus(7), Sebastian Schneeweiß(6), Shirley Wang(6), Gianmario Candore(6), Guido Rasi(5), June Raine(5), Wim Goettsch(4), Hans‐Georg Eichler(4), Spiros Vamvakas(4), Georgy Genov(4), Alison Cave(3), Gerald J. Dal Pan(3), Simone Pinheiro(3), Hua Wei(3), Ana Hidalgo‐Simon(3), Álmath Spooner(3), Gracy Crane(3)